Hungarian Medical Journal
Volume/Issue:
Volume 2: Issue 3
Randomized Placebo-Controlled Trial on the Effect of Corticosteroid on Prolonged Cholestasis due to Acute Hepatitis A
Authors:
Pankaj Jain SMS Medical College Department of Gastroenterology Jaipur India

Search for other papers by Pankaj Jain in
Current site
Google Scholar
PubMed Close
,
Ramesh Roop Rai SMS Medical College Department of Gastroenterology Jaipur India

Search for other papers by Ramesh Roop Rai in
Current site
Google Scholar
PubMed Close
, and
Sandeep Nijhawan SMS Medical College Department of Gastroenterology Jaipur India

Search for other papers by Sandeep Nijhawan in
Current site
Google Scholar
PubMed Close
Pages:
435–441
Online Publication Date:
28 Sep 2008
Publication Date:
01 Sep 2008
Article Category:
Research Article
DOI:
https://doi.org/10.1556/hmj.2.2008.3.10
Keywords:
prolonged cholestatic hepatitis; hepatitis A; prednisolone
Restricted access

Aim and objective: To determine the efficacy and safety profile of corticosteroid on the clinical course of prolonged intrahepatic cholestasis due to acute hepatitis A. Method: We prospectively studied patients of acute hepatitis A with prolonged cholestasis (more than 12 weeks with debilitating symptoms in the form of anorexia, weight loss and pruritis disturbing night sleep) over a period of five years. The patients were randomly assigned to two groups of ursodeoxycholic acid and prednisolone (Group A) and ursodeoxycholic acid and placebo (Group B). They were assessed for cumulative mean decrease in bilirubin at day 3, 7 and then weekly till normalization of bilirubin. Quality of life was assessed in both groups on the basis of pruritis, anorexia, performance status improvement and work hour loss in days. Results: Out of 84 patients of acute hepatitis A, 21 patients had prolonged cholestatic hepatitis. Eleven patients (group A) were given ursodeoxycholic acid and prednisolone. Ten patients (group B) were given ursodeoxycholic acid and placebo. In group A, male: female ratio was 7:4, with a mean age of 21 years (range 13–30 years). The mean bilirubin was 29.4 mg/dl (range 24.9–34.6 mg/dl), aspartate aminotransferase (AST) 104 (range 84–124 U/L), alanine (ALT) aminotransferase 74 U/L (range 51–98 U/L), alkaline phosphatase (AP) 643 (range 460–870 U/L), prothrombin time (PT) prolongation in seconds 3.09 (range 4–7) and protein/albumin 7.1/4.2 (range 7.6–6.4/3.6–4.7 gm/dl). The decrease in bilirubin in group A (cumulative mean) at day 3, 7, 14, 21, 28, 35, 42, 49 was 20.1%, 45.6%, 58.6%, 64.6%, 71.7%, 76.1%, 80.5% and 86.4%, respectively. The mean time for bilirubin normalization was 44 days (range 28–84 days). In group B, male: female ratio 5:5, with a mean age of 21.5 years (range 11–35 years). The mean bilirulin, AST, ALT, AP, PT prolongation (in seconds) protein-albumin were 28.6 (range 11–35 mg/dl), 81 (range 43–112 U/L), 64 U/L (range 39–91 U/L), 702 (range 326–890 U/L), 3.6 (range 2–7) and 6.57/3.7 (range 7.6–5.8/3.2–4.2 gm/dl), respectively. The decrease in bilirubin at day 3, 7, 4, 21, 28, 35, 42, 49 was 2.1%, 5.9%, 11.9%, 19.1%, 25.1%, 29.3%, 33.3% and 38.5%, respectively. The mean time for bilirubin normalization was 94 days (range 74–138 days). p < 0.05 at day 3, 7, 14, 21, 28, 35, 42 and 49 days. Pruritis responded within a mean of 5 days (range 4–8 days) and 24 days (range 18–45 days) in group A and group B, respectively. Anorexia, performance status improvement occurred early in group A and work hour loss was more in group B. None of the patients developed side-effects to corticosteroid. Conclusion: Both groups of prolonged choleastatic hepatitis A were of comparable severity in term of maximal serum bilirubin and transaminases. Prednisolone resulted in symptomatic relief and a rapid initial drop in serum bilirubin levels followed by a persistent fall. No adverse event was recorded. So, prednisolone can be used in debilitating symptoms due to cholestasis in acute viral hepatitis A.

  • Kar, P.: Is there a change in seroepidemiology of hepatitis A infection in India? Indian J. Med. Res., 2006, 123 , 727–729.

    Kar P. , 'Is there a change in seroepidemiology of hepatitis A infection in India? ' (2006 ) 123 Indian J. Med. Res. : 727 -729 .

    • Search Google Scholar

  • Atabek, M. E., Pirgon, O.: Unusual cardiac features in choleastatic hepatitis A in an adolescent: improvement with corticosteroid treatment. J. Infect., 2007, 54 , 91–93.

    Pirgon O. , 'Unusual cardiac features in choleastatic hepatitis A in an adolescent: improvement with corticosteroid treatment ' (2007 ) 54 J. Infect. : 91 -93 .

    • Search Google Scholar

  • Fabris, P., Tositti, G., Mazzella, G. et al.: Effect of ursodeoxycholic acid administration in patient with acute viral hepatitis: a pilot study. Aliment. Pharmacol. Ther., 1999, 13 , 1187–1189.

    Mazzella G. , 'Effect of ursodeoxycholic acid administration in patient with acute viral hepatitis: a pilot study ' (1999 ) 13 Aliment. Pharmacol. Ther. : 1187 -1189 .

    • Search Google Scholar

  • Maier, K.: Clinical significance of cholestatic viral hepatitis. Z. Gastroenterol., 1993, 31 (Suppl. 2) , 71–72.

    Maier K. , 'Clinical significance of cholestatic viral hepatitis ' (1993 ) 31 Z. Gastroenterol. : 71 -72 .

    • Search Google Scholar

  • Schiff, E. R.: Atypical clinical manifestations of Hepatitis A. Vaccine, 1992, 10 (Suppl. 1) , S18–20.

    Schiff E. R. , 'Atypical clinical manifestations of Hepatitis A ' (1992 ) 10 Vaccine : S18 -20 .

    • Search Google Scholar

  • Sciot, R., Damme, B. V., Desmet, V. J.: Cholestatic features in hepatitis A. J. Hepatol., 1986, 3 , 172–181.

    Desmet V. J. , 'Cholestatic features in hepatitis A ' (1986 ) 3 J. Hepatol. : 172 -181 .

    • Search Google Scholar

  • Verucchi, G., Calza, L., Chiodo, F.: Viral hepatitis A with prolonged atypical course. Clinical, biochemical and virologic study of 7 cases. Ann. Ital. Med. Int., 1999, 14 , 239–245.

    Chiodo F. , 'Viral hepatitis A with prolonged atypical course. Clinical, biochemical and virologic study of 7 cases ' (1999 ) 14 Ann. Ital. Med. Int. : 239 -245 .

    • Search Google Scholar

  • Brown, G. R., Persley, K.: Hepatitis A epidemic in the elderly. South Med. J., 2002, 95 , 826–833.

    Persley K. , 'Hepatitis A epidemic in the elderly ' (2002 ) 95 South Med. J. : 826 -833 .

    • Search Google Scholar

  • Eppinger, H.: Die Leberkrankheiten: allgemeine und spezielle Pathologie und Therapie der Leber. Julius Springer, Vienna, 1937.

    Eppinger H. , '', in Die Leberkrankheiten: allgemeine und spezielle Pathologie und Therapie der Leber , (1937 ) -.

  • Watson, C. J., Hoffbauer, W.: The problem of prolonged hepatitis with particular reference to the cholangiolitic type and to the development of cholangiolitic cirrhosis of the liver. Ann. Intern. Med., 1946, 25 , 227.

    Hoffbauer W. , 'The problem of prolonged hepatitis with particular reference to the cholangiolitic type and to the development of cholangiolitic cirrhosis of the liver ' (1946 ) 25 Ann. Intern. Med. : 227 -.

    • Search Google Scholar

  • Texeira, M. R. J., Weller, I. V., Murray, M.: The pathology of hepatitis A in man. Liver, 1982, 2 , 53–60.

    Murray M. , 'The pathology of hepatitis A in man ' (1982 ) 2 Liver : 53 -60 .

  • Flehmig, B., Ranke, M., Berthold, H. et al.: A solid-phase radioimmunoassay for detection of IgM antibodies to hepatitis A virus. J. Infect. Dis., 1979, 140 , 169–175.

    Berthold H. , 'A solid-phase radioimmunoassay for detection of IgM antibodies to hepatitis A virus ' (1979 ) 140 J. Infect. Dis. : 169 -175 .

    • Search Google Scholar

  • Gordon, S. C., Reddy, K. R., Schiff, L. et al.: Prolonged intrahepatic cholestasis secondary to acute hepatitis A. Ann. Intern. Med., 1984, 101 , 635–637.

    Schiff L. , 'Prolonged intrahepatic cholestasis secondary to acute hepatitis A ' (1984 ) 101 Ann. Intern. Med. : 635 -637 .

    • Search Google Scholar

  • Schiff, L.: The use of steroids in liver disease. Medicine, 1966, 45 , 565–573.

    Schiff L. , 'The use of steroids in liver disease ' (1966 ) 45 Medicine : 565 -573 .

  • Williams, R., Billing, B. H.: Action of steroid therapy in jaundice. Lancet, 1961, 2 , 392–396.

    Billing B. H. , 'Action of steroid therapy in jaundice ' (1961 ) 2 Lancet : 392 -396 .

  • Schiraldi, O., Modugno, A., Miglietta, A. et al.: Prolonged viral hepatitis type A with cholestasis: case report. Ital. J. Gastroenterol., 1991, 23 , 364–366.

    Miglietta A. , 'Prolonged viral hepatitis type A with cholestasis: case report ' (1991 ) 23 Ital. J. Gastroenterol. : 364 -366 .

    • Search Google Scholar

  • Mukhopadhya, A., Chandy, G. M.: Generalized lymphadenopathy as a marker of ongoing inflammation in prolonged choleastatic hepatitis A. Eur. J. Gastroenterol. Hepatol., 2002, 14 , 877–888.

    Chandy G. M. , 'Generalized lymphadenopathy as a marker of ongoing inflammation in prolonged choleastatic hepatitis A ' (2002 ) 14 Eur. J. Gastroenterol. Hepatol. : 877 -888 .

    • Search Google Scholar

  • Corpechot, C., Cadranel, J. F., Hoang, C. et al.: Cholestatic viral hepatitis A in adults. Clinical, biological and histopathological study of 9 cases. Gastroenterol. Clin. Biol., 1994, 8 , 743–750.

    Hoang C. , 'Cholestatic viral hepatitis A in adults. Clinical, biological and histopathological study of 9 cases ' (1994 ) 8 Gastroenterol. Clin. Biol. : 743 -750 .

    • Search Google Scholar

  • Mall, M. L., Rai, R. R., Philip, M. et al.: Seroepidemiology of hepatitis A infection in India: changing pattern. Indian J. Gastroenterol., 2001, 20 , 132–135.

    Philip M. , 'Seroepidemiology of hepatitis A infection in India: changing pattern ' (2001 ) 20 Indian J. Gastroenterol. : 132 -135 .

    • Search Google Scholar

  • Batra, Y., Bhatkal, B., Ojha, B. et al.: Vaccination against hepatitis A virus may not be required for schoolchildren in northern India: results of a seroepidemiological survey. Bull. World Health Organ., 2002, 80 , 728–731.

    Ojha B. , 'Vaccination against hepatitis A virus may not be required for schoolchildren in northern India: results of a seroepidemiological survey ' (2002 ) 80 Bull. World Health Organ. : 728 -731 .

    • Search Google Scholar

  • Xu, Z. Y., Li, Z. H., Wang, J. X. et al.: Ecology and prevention of a shell-fish-associated epidemic in Shanghai, China. Vaccine, 1992, 10 (Suppl. 1) , 67–68.

    Wang J. X. , 'Ecology and prevention of a shell-fish-associated epidemic in Shanghai, China ' (1992 ) 10 Vaccine : 67 -68 .

    • Search Google Scholar

  • Hutin, Y. J. F., Pool, V., Cramer, E. H. et al.: A multistate, foodborne outbreak of hepatitis A. N. Engl. J. Med., 1999, 340 , 595–602.

    Cramer E. H. , 'A multistate, foodborne outbreak of hepatitis A ' (1999 ) 340 N. Engl. J. Med. : 595 -602 .

    • Search Google Scholar

  • Wilner, I. R., Uhl, M. D., Howard, S. C. et al.: Serious hepatitis A: an analysis of patients hospitalized during an urban epidemic in the United states. Ann. Int. Med., 1998, 128 , 111–114.

    Howard S. C. , 'Serious hepatitis A: an analysis of patients hospitalized during an urban epidemic in the United states ' (1998 ) 128 Ann. Int. Med. : 111 -114 .

    • Search Google Scholar

  • Vento, S., Garafano, T., Rezini, C. et al.: Fulminant hepatitis associated with Hepatitis A superinfection in patients with chronic hepatitis C. N. Engl. J. Med., 1998, 338 , 286–290.

    Rezini C. , 'Fulminant hepatitis associated with Hepatitis A superinfection in patients with chronic hepatitis C ' (1998 ) 338 N. Engl. J. Med. : 286 -290 .

    • Search Google Scholar
  • Collapse
  • Expand
Cover Hungarian Medical Journal
Hungarian Medical Journal
Print ISSN:
1788-6139
Online ISSN:
1789-0403

Hungarian Medical Journal
Language English
Size  
Year of
Foundation		 2007
Publication
Programme		 ceased
Volumes
per Year		  
Issues
per Year		  
Publisher Akadémiai Kiadó
Publisher's
Address		 H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher		 Chief Executive Officer, Akadémiai Kiadó
ISSN 1788-6139 (Print)
ISSN 1789-0403 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Dec 2024 41 0 0
Jan 2025 29 0 0
Feb 2025 25 0 0
Mar 2025 43 0 0
Apr 2025 9 0 0
May 2025 12 0 0
Jun 2025 10 0 0